Research Paper Volume 12, Issue 11 pp 11025—11041

LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis

Figure 3. LncRNA ADAMTS9-AS2 regulated GC cell proliferation, viability, mobility and EMT by targeting miR-223-3p. CCK-8 assay was used to measure cell proliferation in (A) SGC7901 cells and (C) BGC-823 cells. Cell counting assay by trypan blue staining method was performed to determine cell viability in (B) SGC7901 cells and (D) BGC-823 cells. (E, F) Transwell assay was conducted to measure cell migration in GC cells. Western Blot was employed to examine the expressions of EMT associated proteins (N-cadherin, E-cadherin and Vimentin) in (G, H) SGC7901 cells and (I, J) BGC-823 cells. Each experiment repeated at least 3 times. “NS” represented “no statistical significance”, *P < 0.05, **P < 0.01.